Unresectable Salivary Gland Carcinoma

3 clinical trials · Condition

Record	Firm	Date
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)	National Cancer Institute (NCI)	2021-08-09

Every clearance here is in the API, with alerts when new ones post.